Abstract
PURPOSE: Utility values have been used in the ophthalmic literature to measure the quality of life associated with a health state. By convention, a utility value of 1.0 is associated with perfect health, and a value of 0.0 is associated with death. Construct validity of utility values has been demonstrated, particularly in regard to decreasing utility values as the vision decreases in the better seeing eye, but long-term test-retest reliability has not been demonstrated. The purpose of this study was to demonstrate the test-retest reliability of ophthalmic utility values. METHODS: One hundred fifteen patients with ophthalmic diseases and stable visual acuity underwent time trade-off utility analysis with retesting at various intervals ranging from 1 month to 2 years. The results were analyzed using the Wilcoxon signed rank test. The study was designed to have an 50% power, using a two-sided alpha of 5%, to be able to detect a 10% difference between the test and retest groups. RESULTS: The mean time from testing to retesting was 0.87 years, with a median time of 1.0 year and range of 1 month to 2 years. The mean utility value in the test group was 0.766 (SD = .21; 95% CI, 0.730-0.802), while the mean utility value in the retest group was 0.763 (SD = .22; 95% CI, 0.724-0.802). The difference between the means of the test-retest groups was not significant (P = .99). The intraclass correlation between the initial and follow-up utility scores was .5246 (P < .00005). CONCLUSIONS: Ophthalmic utility values appear to have good test-retest reliability over prolonged periods of time. This information is important because it gives researchers increased confidence in the validity of basic tools for ophthalmic cost-effective (cost-utility) analyses.
Full Text
The Full Text of this article is available as a PDF (62.7 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brown G. C., Brown M. M., Sharma S., Brown H. C. Patient perceptions of quality-of-life associated with bilateral visual loss. Int Ophthalmol. 1998;22(5):307–312. doi: 10.1023/a:1006311910304. [DOI] [PubMed] [Google Scholar]
- Brown G. C., Brown M. M., Sharma S., Brown H., Gozum M., Denton P. Quality of life associated with diabetes mellitus in an adult population. J Diabetes Complications. 2000 Jan-Feb;14(1):18–24. doi: 10.1016/s1056-8727(00)00061-1. [DOI] [PubMed] [Google Scholar]
- Brown G. C., Brown M. M., Sharma S., Brown H., Tasman W. Incremental cost effectiveness of laser photocoagulation for subfoveal choroidal neovascularization. Ophthalmology. 2000 Jul;107(7):1374–1380. doi: 10.1016/s0161-6420(00)00169-x. [DOI] [PubMed] [Google Scholar]
- Brown G. C., Brown M. M., Sharma S. Health care in the 21st century: evidence-based medicine, patient preference-based quality, and cost effectiveness. Qual Manag Health Care. 2000 Fall;9(1):23–31. [PubMed] [Google Scholar]
- Brown G. C., Brown M. M., Sharma S. Quality and cost effectiveness in health care: a unique approach. J Ophthalmic Nurs Technol. 2000 Jan-Feb;19(1):26–30. [PubMed] [Google Scholar]
- Brown G. C., Sharma S., Brown M. M., Garrett S. Evidence-based medicine and cost-effectiveness. J Health Care Finance. 1999 Winter;26(2):14–23. [PubMed] [Google Scholar]
- Brown G. C., Sharma S., Brown M. M., Kistler J. Utility values and age-related macular degeneration. Arch Ophthalmol. 2000 Jan;118(1):47–51. doi: 10.1001/archopht.118.1.47. [DOI] [PubMed] [Google Scholar]
- Brown G. C. Vision and quality-of-life. Trans Am Ophthalmol Soc. 1999;97:473–511. [PMC free article] [PubMed] [Google Scholar]
- Brown M. M., Brown G. C., Sharma S., Garrett S. Evidence-based medicine, utilities, and quality of life. Curr Opin Ophthalmol. 1999 Jun;10(3):221–226. doi: 10.1097/00055735-199906000-00012. [DOI] [PubMed] [Google Scholar]
- Brown M. M., Brown G. C., Sharma S., Garrett S. Evidence-based medicine, utilities, and quality of life. Curr Opin Ophthalmol. 1999 Jun;10(3):221–226. doi: 10.1097/00055735-199906000-00012. [DOI] [PubMed] [Google Scholar]
- Brown M. M., Brown G. C., Sharma S., Kistler J., Brown H. Utility values associated with blindness in an adult population. Br J Ophthalmol. 2001 Mar;85(3):327–331. doi: 10.1136/bjo.85.3.327. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brown M. M., Brown G. C., Sharma S., Shah G. Utility values and diabetic retinopathy. Am J Ophthalmol. 1999 Sep;128(3):324–330. doi: 10.1016/s0002-9394(99)00146-4. [DOI] [PubMed] [Google Scholar]
- Froberg D. G., Kane R. L. Methodology for measuring health-state preferences--II: Scaling methods. J Clin Epidemiol. 1989;42(5):459–471. doi: 10.1016/0895-4356(89)90136-4. [DOI] [PubMed] [Google Scholar]
- Guyatt G. H. A taxonomy of health status instruments. J Rheumatol. 1995 Jun;22(6):1188–1190. [PubMed] [Google Scholar]
- Guyatt G. H., Feeny D. H., Patrick D. L. Measuring health-related quality of life. Ann Intern Med. 1993 Apr 15;118(8):622–629. doi: 10.7326/0003-4819-118-8-199304150-00009. [DOI] [PubMed] [Google Scholar]
- Hollands H., Lam M., Pater J., Albiani D., Brown G. C., Brown M., Cruess A. F., Sharma S. Reliability of the time trade-off technique of utility assessment in patients with retinal disease. Can J Ophthalmol. 2001 Jun;36(4):202–209. doi: 10.1016/s0008-4182(01)80041-7. [DOI] [PubMed] [Google Scholar]
- Lee T. T., Solomon N. A., Heidenreich P. A., Oehlert J., Garber A. M. Cost-effectiveness of screening for carotid stenosis in asymptomatic persons. Ann Intern Med. 1997 Mar 1;126(5):337–346. doi: 10.7326/0003-4819-126-5-199703010-00001. [DOI] [PubMed] [Google Scholar]
- Mangione C. M., Berry S., Spritzer K., Janz N. K., Klein R., Owsley C., Lee P. P. Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons. Arch Ophthalmol. 1998 Feb;116(2):227–233. doi: 10.1001/archopht.116.2.227. [DOI] [PubMed] [Google Scholar]
- Redelmeier D. A., Detsky A. S. A clinician's guide to utility measurement. Prim Care. 1995 Jun;22(2):271–280. [PubMed] [Google Scholar]
- Sharma S., Brown G. C., Brown M. M., Shah G. K., Snow K., Brown H., Hollands H. Converting visual acuity to utilities. Can J Ophthalmol. 2000 Aug;35(5):267–272. doi: 10.1016/s0008-4182(00)80077-0. [DOI] [PubMed] [Google Scholar]
- Steinberg E. P., Tielsch J. M., Schein O. D., Javitt J. C., Sharkey P., Cassard S. D., Legro M. W., Diener-West M., Bass E. B., Damiano A. M. The VF-14. An index of functional impairment in patients with cataract. Arch Ophthalmol. 1994 May;112(5):630–638. doi: 10.1001/archopht.1994.01090170074026. [DOI] [PubMed] [Google Scholar]
- Torrance G. W., Feeny D. Utilities and quality-adjusted life years. Int J Technol Assess Health Care. 1989;5(4):559–575. doi: 10.1017/s0266462300008461. [DOI] [PubMed] [Google Scholar]
- Torrance G. W. Measurement of health state utilities for economic appraisal. J Health Econ. 1986 Mar;5(1):1–30. doi: 10.1016/0167-6296(86)90020-2. [DOI] [PubMed] [Google Scholar]
- Torrance G. W. Utility approach to measuring health-related quality of life. J Chronic Dis. 1987;40(6):593–603. doi: 10.1016/0021-9681(87)90019-1. [DOI] [PubMed] [Google Scholar]
- Weinstein M. C., Stason W. B. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med. 1977 Mar 31;296(13):716–721. doi: 10.1056/NEJM197703312961304. [DOI] [PubMed] [Google Scholar]
- Wilson M. R., Coleman A. L., Yu F., Bing E. G., Sasaki I. F., Berlin K., Winters J., Lai A. Functional status and well-being in patients with glaucoma as measured by the Medical Outcomes Study Short Form-36 questionnaire. Ophthalmology. 1998 Nov;105(11):2112–2116. doi: 10.1016/S0161-6420(98)91135-6. [DOI] [PubMed] [Google Scholar]